Lowe to present cancer research findings at Harvard summitThursday, April 27, 2017
Jamaican cancer research scientist Dr Henry Lowe will be heading to Harvard Medical School in Boston, Massachusetts, this weekend, to participate in the 2017 Global Health Catalyst Summit.He is expected to discuss his research findings on cannabis and cancer.
Dr Lowe will also participate in the innovative partnerships/collaborations in curbing the growing global burden of noncommunicable diseases like cancer.
The Global Health Catalyst (GHC) summit at Harvard is said to be a premier annual event designed to catalyse high-impact international collaborations to eliminate global health disparities with a focus on cancer.
Dr Lowe, who in 2013 founded Jamaica's first medical cannabis company, Medicanja Limited, is recognised globally for his research on the potential for plant-based compounds to treat a range of chronic diseases, particularly cancer.
“I was very pleased but humbled to realise that my scientific research work is being so highly recognised internationally at this time. It therefore inspires me to continue my research, despite the many obstacles encountered from time to time. Drug research and development not only requires specialised skills and hard work, but also financial support, which is hard to realise,” he said.
Over the years, the summit has accelerated collaborations to establish or support cancer centres and health care institutions in different African countries, launched education and training efforts to build human capacity needed to strengthen the health care systems, and established new research collaborations, along with disease prevention and advocacy programmes.
Dr Lowe has, for over 50 years, been at the forefront of numerous scientific research discoveries, the most recent being a breakthrough in the treatment of Hepatitis C using 1 cannabidiol (CBD), one of the most prevalent chemical compounds in the ganja plant.
In addition, he has made significant strides in the discovery and development of drugs derived from the cannabis plant for the treatment of cancers and neurodegenerative diseases.
Dr Lowe has had more than 25 years' experience in cancer research geared at finding affordable and appropriate treatment and cure for cancers, particularly prostate, breast, melanoma, and leukaemia.
He has so far been awarded four patents from the US Patents Office and has four patents pending that are expected to be granted by the end of this year.
Dr Lowe is an adjunct professor at the University of Maryland Medical School; a distinguished professor of ethno medicinal chemistry at the University of Technology, Jamaica; and was recently appointed professor at the University of the West Indies, Mona, medical school.
Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at https://bit.ly/epaper-login